Banking on carbon

 

Science Translational Medicine Magazine selected a research, which Dr Gigi Chiu from the Department of Pharmacy is one of the two corresponding authors, and highlighted under the Editor’s Choice in its Volume 5, issue 191.

 

The same study was selected as one of the top stories in version 5.22 of Cord Blood News, a free, weekly online newsletter sent to international members of the cord blood community.

 

ChiuNgarCheeGigi
Dr Gigi Chiu, faculty member of the Department of Pharmacy, NUS.  

 

Umbilical cord blood, commonly known as just cord blood, is an increasingly popular source of hematopoietic stem and progenitor cells for treating a wide variety of blood disorders, including cancers and metabolic diseases. However, cord blood-based treatments are mostly limited to children and adults with low body weights. This study showed that there is good potential that carbon nanotubes could be used as scaffolds to improve the expansion and possibility of hematopoietic stem and progenitor cells from human cord blood.

 

Their research, entitled “Protective Role of Functionalized Single Walled Carbon Nanotubes Enhance Ex Vivo Expansion of Hematopoietic Stem & Progenitor Cells in Human Umbilical Cord Blood” has been published in Nanomedicine: Nanotechnology, Biology and Medicine.